Cargando…
Barriers to deprescribing anti-depressants in a primary care setting; an observational study - Are SSRI drugs of dependence and should these be re classified as schedule 3 drugs
INTRODUCTION: There has been an exponential rise in SSRI prescribing, between 2021 and 2022 there was a 5% increase. The majority of SSRI prescription initiation takes place in primary care. This is a national trend and mirrored internationally. OBJECTIVES: The study was undertaken to understand bar...
Autores principales: | Patel, A., Rasheed, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479070/ http://dx.doi.org/10.1192/j.eurpsy.2023.1748 |
Ejemplares similares
-
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials
por: Crisafulli, Salvatore, et al.
Publicado: (2021) -
The SSRI Clinic: Improving SSRI Prescribing Safety in Outpatient CAMHS Clinic
por: Morgan, Tammy, et al.
Publicado: (2022) -
A practitioner behaviour change intervention for deprescribing in the hospital setting
por: Scott, Sion, et al.
Publicado: (2020) -
Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment
por: Edvinsson, Åsa, et al.
Publicado: (2020) -
Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)